Clinical and Immunohistochemical Determinants of Hepatocellular Carcinoma in Archival Liver Biopsies in Meru, Kenya
This study in Meru, Kenya, found that while clinical risk factors like HBV infection and hepatic fibrosis showed directional associations with hepatocellular carcinoma (HCC) without reaching statistical significance in a small cohort, the combined immunohistochemical marker pattern of Hep Par-1 positive and AE1/AE3 negative proved to be a highly accurate and valuable diagnostic tool for distinguishing HCC from metastatic liver carcinoma in resource-limited settings.